Compare Piramal Healthcare with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs LUPIN - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES LUPIN PIRAMAL ENTERPRISES/
LUPIN
 
P/E (TTM) x 17.3 105.9 16.4% View Chart
P/BV x 1.2 2.4 47.8% View Chart
Dividend Yield % 1.5 0.0 -  

Financials

 PIRAMAL ENTERPRISES   LUPIN
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
LUPIN
Mar-19
PIRAMAL ENTERPRISES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs3,303986 334.9%   
Low Rs1,797720 249.4%   
Sales per share (Unadj.) Rs716.5369.5 193.9%  
Earnings per share (Unadj.) Rs79.713.4 594.6%  
Cash flow per share (Unadj.) Rs107.937.4 288.6%  
Dividends per share (Unadj.) Rs28.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs1,477.5303.7 486.5%  
Shares outstanding (eoy) m184.45452.49 40.8%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x3.62.3 154.1%   
Avg P/E ratio x32.063.6 50.3%  
P/CF ratio (eoy) x23.622.8 103.5%  
Price / Book Value ratio x1.72.8 61.4%  
Dividend payout %35.10-   
Avg Mkt Cap Rs m470,292386,064 121.8%   
No. of employees `0007.817.7 44.2%   
Total wages/salary Rs m22,50431,513 71.4%   
Avg. sales/employee Rs Th16,899.49,453.8 178.8%   
Avg. wages/employee Rs Th2,877.71,782.0 161.5%   
Avg. net profit/employee Rs Th1,879.9343.0 548.1%   
INCOME DATA
Net Sales Rs m132,153167,182 79.0%  
Other income Rs m3,1283,640 85.9%   
Total revenues Rs m135,281170,822 79.2%   
Gross profit Rs m66,29028,822 230.0%  
Depreciation Rs m5,20210,850 47.9%   
Interest Rs m44,0973,078 1,432.5%   
Profit before tax Rs m20,11918,534 108.6%   
Minority Interest Rs m3,194-89 -3,576.5%   
Prior Period Items Rs m038 0.0%   
Extraordinary Inc (Exp) Rs m0-3,400 0.0%   
Tax Rs m8,6119,017 95.5%   
Profit after tax Rs m14,7016,066 242.4%  
Gross profit margin %50.217.2 291.0%  
Effective tax rate %42.848.7 88.0%   
Net profit margin %11.13.6 306.6%  
BALANCE SHEET DATA
Current assets Rs m122,742138,536 88.6%   
Current liabilities Rs m310,81061,299 507.0%   
Net working cap to sales %-142.346.2 -308.0%  
Current ratio x0.42.3 17.5%  
Inventory Days Days2384 27.5%  
Debtors Days Days39112 34.5%  
Net fixed assets Rs m116,904127,516 91.7%   
Share capital Rs m369905 40.8%   
"Free" reserves Rs m272,161136,517 199.4%   
Net worth Rs m272,530137,422 198.3%   
Long term debt Rs m270,19666,417 406.8%   
Total assets Rs m856,261279,494 306.4%  
Interest coverage x1.57.0 20.7%   
Debt to equity ratio x1.00.5 205.1%  
Sales to assets ratio x0.20.6 25.8%   
Return on assets %6.93.3 209.9%  
Return on equity %5.44.4 122.2%  
Return on capital %12.48.9 139.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,20059,414 25.6%   
Fx outflow Rs m4,88922,282 21.9%   
Net fx Rs m10,31237,132 27.8%   
CASH FLOW
From Operations Rs m-115,97516,660 -696.1%  
From Investments Rs m-8,265-32,825 25.2%  
From Financial Activity Rs m107,5257,441 1,445.0%  
Net Cashflow Rs m-16,650-8,724 190.9%  

Share Holding

Indian Promoters % 52.9 46.6 113.5%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 4.0 11.3 35.4%  
FIIs % 26.6 31.9 83.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 10.1 163.4%  
Shareholders   93,274 98,259 94.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  WOCKHARDT  AUROBINDO PHARMA  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Flat; L&T and Tech Mahindra Top Losers(12:30 pm)

Share markets in India are presently trading on a volatile note. Sectoral indices are trading mixed with stocks in the capital goods sector and realty sector.

Related Views on News

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Nov 13, 2019 01:21 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS